Valuation: M3, Inc.

Market Cap 1,267B 7.81B 6.83B 6.3B 5.79B 10.98B 752B 11.17B 75.25B 29.52B 368B 29.35B 28.7B P/E 2027 *
23.2x
P/E 2028 * 20.7x
Enterprise Value 1,127B 6.95B 6.08B 5.61B 5.16B 9.77B 669B 9.94B 66.96B 26.27B 327B 26.12B 25.54B EV / Sales 2027 *
2.87x
EV / Sales 2028 * 2.55x
Free-Float
58.5%
Yield 2027 *
1.3%
Yield 2028 * 1.43%
1 day-22.25%
3 months-22.25%
6 months-38.91%
Current year-37.85%
Current year 8.55
Extreme 8.552
14
1 year 8.55
Extreme 8.552
15.25
3 years 8.33
Extreme 8.33
19.15
5 years 8.33
Extreme 8.33
73.19
10 years 0
Extreme 0
102
Manager TitleAgeSince
President 61 29/09/2000
Investor Relations Contact 46 -
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member 61 29/09/2000
Director/Board Member 53 01/06/2012
Director/Board Member 61 01/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
-22.25%-.--% - - 7.81B
+2.11%+3.07%-6.29%+43.88% 543B
+0.20%-2.53%-41.54%+66.73% 310B
+0.82%-1.26%-21.19%+62.39% 148B
+16.13%+38.20%+698.84%+2,837.30% 122B
+0.90%+0.03%-31.68%+182.15% 99.8B
-0.22%+3.92%-14.73%+31.42% 99.67B
+1.26%+3.80%+8.67%+3.52% 88.06B
+1.26%+0.43%-19.69%+126.49% 82.86B
+4.88%-0.34%-19.72%+30.18% 41.14B
Average +0.47%+0.94%+61.41%+376.01% 170.52B
Weighted average by Cap. +2.44%-0.21%+38.85%+282.60%

Financials

2027 *2028 *
Net sales 393B 2.42B 2.12B 1.95B 1.8B 3.4B 233B 3.46B 23.32B 9.15B 114B 9.1B 8.9B 430B 2.65B 2.32B 2.14B 1.96B 3.72B 255B 3.79B 25.51B 10.01B 125B 9.95B 9.73B
Net income 54.17B 334M 292M 270M 248M 469M 32.16B 477M 3.22B 1.26B 15.72B 1.25B 1.23B 60.61B 374M 327M 302M 277M 525M 35.98B 534M 3.6B 1.41B 17.58B 1.4B 1.37B
Net Debt -139B -860M -752M -694M -638M -1.21B -82.77B -1.23B -8.28B -3.25B -40.45B -3.23B -3.16B -170B -1.05B -916M -845M -777M -1.47B -101B -1.5B -10.09B -3.96B -49.29B -3.94B -3.85B
Logo M3, Inc.
M3 Inc is a Japan-based company mainly engaged in the provision of services centering on the platform of healthcare. The Company has five business segments. Medical Platforms segment conducts marketing-related businesses in Japan utilizing the Internet and real operations centered on medical employee specialized site m3.com. Evidence Solution segment is engaged in the contract research organization (CRO) business that supports clinical development work and research, and site management organization (SMO) business that manages the clinical trial operations. Career Solutions segment is engaged in human resource services for healthcare professionals. Site Solution segment provides operational support for medical institutions and home-visit nursing services. Overseas segment provides services of medical related marketing support, research and careers, utilizing the medical employee specialized sites in the United States, the United Kingdom, China, Korea, India, France, Germany and Spain.
Employees
17,010
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,898.00JPY
Average target price
2,158.33JPY
Spread / Average Target
+13.72%

Quarterly revenue - Rate of surprise